United Kingdom · Question · Written question
UIN 101889
NHS: Drugs
Original
Introduced
2 January 2026
Last action
12 January 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
12 January 2026
Summary
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of NHS spending on pharmaceutical products on patients in the context of the UK-US trade deal.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
2 January 2026
Written question
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of NHS spending on pharmaceutical products on patients in the context of the UK-US trade deal.
Source: Commons
12 January 2026
Answer
Every patient deserves access to the best possible treatment. By increasing the standard National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold, we are increasing the value that we place on innovations that deliver improveme...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-01-02/101889
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1867035
- uk · wq-1867035 · source updated 12 January 2026